NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,286,543 | -17.7% | 797,436 | -9.5% | 33.31% | +15.1% |
| Q2 2023 | $42,890,676 | -12.4% | 881,436 | 0.0% | 28.95% | -10.5% |
| Q1 2023 | $48,937,327 | +38.2% | 881,436 | 0.0% | 32.36% | +36.0% |
| Q4 2022 | $35,407,284 | -26.8% | 881,436 | -20.2% | 23.78% | +21.7% |
| Q3 2022 | $48,403,000 | +46.9% | 1,104,581 | +18.8% | 19.54% | +9.2% |
| Q2 2022 | $32,944,000 | -28.2% | 929,581 | -17.6% | 17.89% | -17.8% |
| Q1 2022 | $45,886,000 | -32.0% | 1,127,981 | +56.2% | 21.78% | +5.5% |
| Q4 2021 | $67,444,000 | +9.4% | 722,181 | +30.5% | 20.63% | +2.8% |
| Q3 2021 | $61,668,000 | +18.6% | 553,381 | +20.8% | 20.06% | +2.5% |
| Q2 2021 | $51,994,000 | +55.7% | 457,981 | +39.3% | 19.56% | +19.9% |
| Q1 2021 | $33,390,000 | -41.1% | 328,836 | -42.3% | 16.31% | -3.4% |
| Q4 2020 | $56,686,000 | – | 569,602 | – | 16.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |